Tag

Nice

All articles tagged with #nice

France’s National Rally Bets on Momentum After Mixed Local Elections
politics19 days ago

France’s National Rally Bets on Momentum After Mixed Local Elections

France’s far-right National Rally claimed momentum for the 2027 presidential race after a mixed local-vote night, with wins in Nice and several southern towns but failures to capture marquee cities like Marseille, Toulon and Nîmes; leader Jordan Bardella hailed a “biggest breakthrough” and ongoing local implantation, while critics warned that runoff dynamics could still block a national breakthrough, as polls put Bardella ahead in the first round (about 35%) and traditional parties race to unite against the extremes.

NHS adds non-hormonal option for menopausal hot flashes
health1 month ago

NHS adds non-hormonal option for menopausal hot flashes

England's NHS will offer Veoza (fezolinetant) as a non-hormonal treatment for menopausal hot flushes and night sweats when HRT cannot be used; NICE says it’s cost-effective and could help up to 500,000 women. Not recommended for those with breast cancer, other estrogen‑dependent cancers, or liver disease; HRT remains the first-line option. The decision applies in England; Wales and Northern Ireland often follow NICE guidance, while Scotland has not yet recommended NHS use.

Experts Warn of Unnecessary Overtreatment for Men with Prostate Cancer
health8 months ago

Experts Warn of Unnecessary Overtreatment for Men with Prostate Cancer

Experts warn that outdated guidelines may lead to unnecessary overtreatment of up to 5,000 men annually with prostate cancer in England, risking serious side effects. The charity Prostate Cancer UK calls for NICE to update its guidance to better reflect recent advances in testing and diagnosis, promoting active surveillance for low-risk cases to prevent harm and reduce the 'postcode lottery' in treatment approaches.

NHS urged to support weight-loss jab users for a year post-treatment
health8 months ago

NHS urged to support weight-loss jab users for a year post-treatment

The National Institute for Health and Care Excellence (NICE) recommends providing structured support for up to a year after stopping weight-loss medications like Mounjaro or Wegovy to prevent weight regain, emphasizing long-term behavioral habits and community support, especially for NHS patients, while highlighting the role of pharmacies in ongoing weight management efforts.

French Authorities Link Recent Riviera Blackouts to Sabotage
world10 months ago

French Authorities Link Recent Riviera Blackouts to Sabotage

Two anarchist groups in France claimed responsibility for a power outage that affected over 160,000 homes in Nice and surrounding areas, including the Cannes Film Festival, through arson attacks on electrical infrastructure. The incident caused disruptions to vital services, but power was restored within hours, and authorities are increasing security around electrical sites.

NHS Limits Initial Access to Lilly's Mounjaro for Obesity Treatment
health1 year ago

NHS Limits Initial Access to Lilly's Mounjaro for Obesity Treatment

The NHS in England plans to roll out the weight-loss drug Mounjaro, but it may take up to 12 years for full implementation due to concerns about overwhelming healthcare services. The drug, recommended by NICE, will initially be available to those with a BMI over 35 and an obesity-related health issue. The phased rollout aims to prioritize those with the highest clinical need, with an estimated 220,000 people benefiting in the first three years. The decision has sparked disappointment among patient groups due to the lengthy timeline.

UK to Offer Eli Lilly's Mounjaro Weight-Loss Drug on NHS
health1 year ago

UK to Offer Eli Lilly's Mounjaro Weight-Loss Drug on NHS

Britain's medical costs regulator, NICE, has recommended Eli Lilly's weight-loss drug Mounjaro for certain obese patients without a time limit on its use, unlike Novo Nordisk's Wegovy. The draft roadmap suggests Mounjaro for patients with a BMI of at least 35 and one weight-related co-morbidity, with a review if less than 5% weight loss occurs after 6 months. The final decision is expected on October 30 after public comments.